Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 03 1997, 578-583, Vol 35, No. 3
GJ Doellgast, JE Brown, JA Koufman and CL Hatheway
The measurement of chicken and human antibodies to Clostridium botulinum
neurotoxins A, B, and E was accomplished by affinity isolation of complexes
containing these antibodies. By this approach, a mixture of toxin with the
test antibody, fluoresceinated antibody, and enzyme (Russell's viper venom
factor X activator)-labeled antibody is allowed to form a complex in
solution phase. This complex is then bound to a matrix containing
antifluorescein antibody. All components not bound to the matrix are washed
off, and the complex is isolated intact by elution with fluorescein, which
competes with the complex for binding to the antifluorescein matrix. The
eluted complex is then bound to a matrix which specifically binds the test
antibody (anti-chicken immunoglobulin Y [IgY] or anti-human IgG), and the
bound complex is measured by using the enzyme label. Using this approach,
we were able to measure as little as 1 ng of specific antibody per ml from
affinity- isolated, monospecific chicken antibody preparations and to
measure antibody specifically from IgY fractions of monospecific chicken
antibody preparations. Human antibodies from subjects immunized with
pentavalent toxoid preparations were detectable at dilutions as great as
24,300-fold, and undiluted serum from most control subjects showed no
measurable antibody. Antibody was also measured in 65 subjects who were
receiving preparations of neurotoxin A (BOTOX) for the treatment of spastic
disorders. Eighteen of them had toxin-specific antibody reactive with toxin
B, and two of them had toxin-specific antibody reactive with toxin A. The
two patients having antibody to toxin A were refractory to treatment with
this toxin. This approach of isolation of hapten-labeled immune complexes
under nondenaturing conditions with hapten is broadly applicable to the
specific measurement of antibodies present at very low concentrations in
serum.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Sensitive assay for measurement of antibodies to Clostridium botulinum neurotoxins A, B, and E: use of hapten-labeled-antibody elution to isolate specific complexes
Department of Biochemistry, Bowman Gray School of Medicine, Winston- Salem, North Carolina 27157-1016, USA. gdoellga@bgsm.edu
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|